PART1 and central nervous system cancer: Deng et al. [111] found that LncRNA PART1 and SALL1 are underexpressed, while miR-374b is upregulated in glioma, and confirmed that LncRNA PART1 targeted miR-374b to promote SALL1 expression, which inhibits glioma cell proliferation and migration.